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Hemodynamic Variables and Left Ventriculography 
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WOLFGANG KUBLER, MD, FACC 
Heidelberg, West Germany and Boston, Massachusetts 
Increasingly longer balloon inflation times during coro-
nary angioplasty can create significant left ventricular 
ischemia, amelioration of which was attempted in this 
study using nitroglycerin. Hemodynamic variables were 
assessed during inflation of an angioplasty balloon in the 
proximal left anterior descending coronary artery of 10 
patients. Regional wall motion was assessed by left ven-
triculography during a separate balloon inflation. Ni-
troglycerin (200 /Lg) was then administered intrave-
nously, and hemodynamic and ventriculographic 
assessments during balloon inflations were repeated. 
Balloon inflation resulted in a marked increase in left 
ventricular end-diastolic pressure (from 9.2 ± 2.1 to 
19.4 ± 2.9 mm Hg) and time constant ofieft ventricular 
relaxation (from 44.2 ± 6.2 to 62.3 ± 11.3 ms) and a 
decrease in distal coronary artery perfusion pressure 
(from 54 ± 9 to 33.1 ± 4 mm Hg). Time to onset of 
angina was 29 ± 3 seconds and time to ST segment 
depression of I mm or greater was 30 ± 3 seconds. 
Regional wall motion analysis 30 seconds after onset of 
balloon inflation revealed marked hypokinesia and 
Bi:l!loon inflation during percutaneous transluminal coronary 
angioplasty necessarily prevents anterograde coronary artery 
flow in the respective vessel. The resultant ischemia is usu-
ally not clinically problematic, because balloon inflation 
times are relatively short and ischemic manifestations gen-
erally resolve rapidly after balloon deflation. Occasionally, 
patients experience profound signs and symptoms of myo-
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akinesia in the anteroapical segments with graduated 
depression of inferibr wall motion, greatest at the apex. 
After the administration of nitroglycerin, balloon in-
flation resulted in a smaller increase in end-diastolic 
pressure (from 5.0 ± 2.7 to 8.3 ± 2.6 mm Hg) and time 
constant (from 47.9 ± 4.7 to 54.4 ± 9.2 ms; both p < 
0.01 versus standard balloon inflation). Distal coronary 
artery pressure remained similar to standard balloon 
inflation (32 ± 3 mm Hg) despite lower mean arterial 
pressure (89 ± 5 mm Hg, p :s; 0.01). Time to onset of 
angina (58 ± 6 seconds) and time to 1 mm ST segment 
depression (62 ± 8 seconds) were both significantly de-
layed (p :s; 0.01). Anteroapical segmental wall motion 
was unchanged, but motion in the three inferoapical 
segments was significantly improved after nitroglycerin 
(p :s; 0.05). Thus, nitroglycerin administration results 
in salutary effects when used before the balloon inflation 
of coronary angioplasty, probably at least in part as a 
result of amelioration of left ventricular ischemia. 
(] Am Coli Cardiol 1985;6:267-74) 
cardial ischemia during balloon inflation, interfering with 
procedure safety and possibly completion, hi addition, in-
dications for this procedure are gradually expanding to in-
clude patients with unstable angina and impaired left ven-
tricular function, and it is becoming more common to apply 
this procedure to multiple lesions in a single sitting. In-
creasing the time of an individual inflation may also increase 
the efficacy of dilation (l,2). Consequently, the extent and 
duration of the iatrogenic myocardial ischemia during bal-
loon inflation have increased. In one early study (3), total 
coronary occlusion time ranged up to 25 minutes. Finaily, 
repeated short periods of ischemia, which individually would 
have no long-term sequelae, have been reported (4) to cu-
mulatively impair left ventricular function in a slowly re-
versible if not permanent manner. Preliminary work (5) has 
shown that such impairment follows the balloon inflations 
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of angioplasty. Thus, limitation of this iatrogenic ischemia 
may be useful. 
Attempts to ameliorate such ischemic changes in patients 
undergoing coronary angioplasty by administering intra-
coronary nifedipine (4) or intracoronary nitroglycerin (6) 
have been reported. However, the administration of intra-
coronary nitroglycerin before or during coronary occlusion 
may have no advantage over systemic administration, given 
the evidence of the substantial systemic effects of nitro-
glycerin (7). Therefore, we attempted to modify ischemic 
changes induced by balloon inflation using intravenous 
nitroglycerin. 
Methods 
Patient selection. The patient group consisted of 12 pa-
tients with isolated, high grade stenosis of the proximal left 
anterior descending coronary artery, befote or at the origin 
of the first septal perforator. The patients were studied after 
an overnight fast, and no routine premedications were given. 
Intracoronary nitroglycerin had been used diagnostically 
during their first cardiac catheterization and, therefore, was 
not repeated during these studies. The 10 patients in whom 
the stenosis was successfully passed by the angioplasty cath-
eter are described in this report. The eight men and two 
women ranged in age from 45 to 68 yeats. All patients were 
in sinus rhythm at the time of study. Three patients had a 
clinical history of a previous myocardial infarction, but none 
had a Q wave on the electrocardiogram. . 
Data acquisition and angioplasty procedure. Left 
ventricular pressures were measured using a micromanom-
eter-tipped catheter (Millar Instruments) with a central 
lumen designed for high speed contrast injection. The mi-
cromanometer was calibrated externally against a mercury 
reference standard and matched simultaneously against lu-
minal pressure. Aortic pressure was measured using an 8F 
guiding catheter and distal coronary artery pressure was 
measured using the distal lumen of the balloon catheter. 
Gruentzig angioplasty catheters (Schneider-Medintag, 
Zurich; balloon length 20 mm, width 2.0 to 3.0 mm) were 
used in this study, and in all cases the inflated balloon 
completely occluded the coronary artery lumen. The distal 
catheter lumen and the guiding catheter were connected to 
Statham P23Db transducers by way of fluid-filled tubing. 
Catheter lumens, especially in the balloon catheter, were 
flushed regularly and frequently to maintain fidelity. The 
design characteristics of the Gruentzig catheters favor ac-
curate measurement of distal pressures (8). Coronary wedge 
pressure was defined as the pressure recorded from the distal 
lumen of the balloon catheter during balloon inflation. 
Myocardial perfusion pressure was roughly assessed us-
ing a perfusion index, defined as (distal coronary artery 
pressure [wedge] - left ventricular end-diastolic pressure). 
The use of left ventricular end-diastolic pressure is justified 
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by the fact that decreases in left ventricular end-diastolic 
pressure after nitroglycerin closely parallel in magnitude 
other decreases in left and right heart filling pressures (9). 
Left ventricular angiography was performed with iohexol, 
40 to 50 ml injected over 3 seconds. This nonionic contrast 
agent was used to minimize contrast-induced alterations in 
cardiac physiology. All pressures were averaged over at 
least five beats to minimize the effects of respiration. Limb 
leads I, II and III were recorded continuously during the 
procedure. Electrocardiographic ischemia was defined as the 
development of at least I mm elevation or depression of the 
ST segment in any lead. 
Protocol. The protocol for this study was approved in 
October 1983 by the Ethical Committee of the University 
Clinic, University of Heidelberg, and all patients gave in-
formed consent. The hemodynamic responses to two inter-
ventions were assessed: I) during the standard inflation of 
the angioplasty balloon and occlusion of the stenotic vessel, 
and 2) during a similar inflation of the balloon, but after 
the administration of intravenous nitroglycerin. Control 
pressures were measured initially in all patients, and then 
a control left ventricular angiogram was performed before 
the balloon catheter was introduced into the coronary artery. 
Once the balloon was successfully positioned across the 
stenosis, one or two "therapeutic" balloon inflations were 
carried out before the investigational protocol resumed. These 
inflations were performed to minimize the possibility that 
abrupt increases in trans stenotic flow at rest due to reduction 
of stenosis would change the measured variables during the 
protocol. Hemodynamic variables were recorded during a 
subsequent balloon inflation. After a return of pressure to 
control values, a ventriculogram was carried out during 
repeat balloon inflation, the contrast injection beginning 30 
seconds after balloon inflation was begun. Then nitroglyc-
erin (200 /Lg) was given as an intravenous bolus over ap-
proximately 30 seconds. Thirty seconds later balloon infla-
tion was repeated and hemodynamic variables were recorded. 
After these variables returned to control values, the nitro-
glycerin injection was repeated, followed in 30 seconds by 
balloon inflation and 30 seconds later by a ventriculogram. 
In all cases measured values Were allowed to return to 
control values before the next balloon inflation. This petiod 
was not prohibitively long, given the relatively short sys-
temic effects of intravenous bolus nitroglycerin (10) and 
nonionic dye (11). In addition, a wait of at least 7 minutes 
after angiograms was assured. The ventriculogram during 
the standard balloon inflation was done during at least the 
third or fourth balloon inflation, whereas the comparison 
ventriculogram after nitroglycerin administration was ob-
tained during the next two inflations (at least the fifth or 
sixth balloon inflation). A recovery time was allowed be-
tween inflations. 
Although assessment of wall motion changes was per-
formed after only 30 seconds of balloon inflation, this time 
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interval is likely to be adequate given the rapid onset and 
rapid steady state formation of left ventricular dysfunction 
during the balloon inflation period of angioplasty (12). No 
effort was made to extend balloon inflation time to clinically 
tolerated limits. Patients were carefully instructed to inform 
the laboratory staff immediately when chest discomfort oc-
curred. Subsequent questioning established whether this re-
sembled their typical anginal chest pain. During the entire 
protocol the number of dilations performed per patient was 
6.1 ± 1.2 (range 5 to 8), and the average duration per 
occlusion was 62 ± 14 seconds. No patient had a com-
plication of any type during the study. 
Data analysis. A digital display position marker for the 
X-ray apparatus assured identical filming positions relative 
to the patient for multiple left ventriculograms. Left ven-
tricular angiograms were filmed at 50 frames/s in the 30° 
right anterior oblique projection during slight inspiration 
without Val salva maneuver. Total body radiation exposure 
was estimated to be 3 mrem for each of the three ventric-
ulograms. Films were analyzed when projected using a hand-
held digitizer, and the left ventricular volumes, ejection 
fraction (area-length method) and segmental wall motion 
(modified Leighton method) (Fig. I) (\ 3) were assessed 
using a dedicated hardware-software unit (Mennen Medi-
cal). All beats after premature ventricular complexes were 
excluded, and the first or second fully opacified beat was 
used to minimize contrast-induced changes. 
Dyssynchronous early diastolic wall motion was quali-
tatively assessed in each myocardial segment produced by 
this system. Such motion was judged to be present if max-
imal inward wall motion occurred after the start of left 
ventricular relaxation, the latter defined by the development 
of peak negative dP/dT (first derivative of pressure). For 
measurement of the left ventricular relaxation variables, 
pressure tracings recorded at a paper speed of 100 mm/s 
were digitized at 4 ms intervals and the time constant of 
isovolumic relaxation derived (T). In brief, the negative 
reciprocal of the slope of the linear regression of In pressure 
and time coordinates (Tau, or T) was calculated using the 
equation In P = - tiT + b. The correlation coefficient of 
the best regression fit was always greater than 0.99 in the 
beats reported in this paper. Coordinates were taken from 
the isovolumic period, which extended from the time of 
peak negative dP/dT until mitral valve opening, assumed to 
be when pressure decreased to 5 mm Hg above the left 
ventricular end-diastolic pressure of the previous beat. It 
has been suggested that isovolumic relaxation may be biex-
ponential (12,14) and, thus, T was analyzed in terms of the 
T, and T 2 components, representatives of the first and sec-
ond halves of isovolumic relaxation. T, may be more sen-
sitive to the early diastolic dyssynchronous wall motion 
found during coronary occlusion (vide infra). T, was defined 
as the time constant of the first 40 ms of isovolumic relax-
ation and T 2 as the time constant from 40 to 80 ms after 
DOOREY ET AL. 269 
ANGIOPLASTY ISCHEMIA RELIEF WITH NITROGLYCERIN 
negative dP/dT or to mitral valve opening, whichever oc-
curred first. The best fit coefficient was similar for the biex-
ponential and the monoexponential fittings. 
Statistics. Statistical comparisons were made using the 
Wilcoxon rank sum test with the Bonferroni correction for 
multiple comparisons. 
Results 
Hemodynamic data. During standard inflation of the 
angioplasty balloon, left ventricular end-diastolic pressure 
and T, T, and T 2 increased significantly, whereas mean 
arterial pressure, dP/dT and negative dP/dT decreased sig-
nificantly (Table I). Distal coronary artery pressure de-
creased markedly, whereas mean coronary pressure proxi-
mal to the stenosis decreased only slightly during balloon 
inflation (Table 2). Heart rate remained unchanged during 
and after balloon inflation. After balloon deflation, hemo-
dynamic variables rapidly recovered, usually within 20 sec-
onds but never requiring more than 60 seconds for renor-
malization. When nitroglycerin administration preceded 
balloon inflation, baseline values immediately before bal-
loon inflation were significantly lower than control values 
for left ventricular end-diastolic, peak left ventricular and 
mean arterial pressures (Table I). T, T" T 2 and mean distal 
coronary pressure remained unchanged. Heart rate increased 
slightly from 69 to 75 beats/min. After administration of 
nitroglycerin, changes in left ventricular end-diastolic pres-
sure, end-systolic volume, dP/dT, T and T, during balloon 
inflation were significantly attenuated. 
Left ventricular wall motion. During inflation of the 
angioplasty balloon, segmental motion decreased markedly 
in anterior, apical and inferoapical segments, as did global 
ejection fraction (Table 3). Only the basal anterior and basal 
inferior segmental functions failed to decrease significantly. 
Balloon inflation after nitroglycerin administration resulted 
in improved segmental motion compared with standard bal-
loon inflation in apical inferior and midinferior segments. 
The segmental function of anterior regions was not improved 
compared with standard balloon inflation but global ejection 
fraction increased slightly, although not significantly, and 
was still depressed when compared with control. In the 10 
patients, dyssynchronous wall motion was present in 2 of 
90 segments in the control ventriculogram, but in 15 of 90 
segments during standard balloon inflation. During balloon 
inflation after nitroglycerin, only 4 of 90 segments were 
dyssynchronous (p :s 0.01). 
Left ventricular pressure-volume relation. The left 
ventricular pressure-volume relation was displaced upward 
and to the right during balloon inflation, resulting in a higher 
pressure at any given diastolic volume (Fig. 2). Nitroglyc-
erin administration before balloon inflation resulted in a 
blunting of this alteration. 
Chest pain and electrocardiographic changes. During 
standard balloon inflation, 8 of the 10 patients complained 
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Table 1. Hemodynamic Variables in IO Patients During Control Period and Maximal Change Recorded During Balloon Inflation 
Alone and Balloon Inflation Preceded by Nitroglycerin Administration 
Control PTCA Control 2 TNG TNG-PTCA 
Heart rate (beats/min) 69 ± 4 70 ± 5 68 ± 5 76 ± 3* 73 ± 3 
L VEDP (mm Hg) 9.2 ± 2.1 19.4 ± 2.9t 8.6 ± 3.8 5.0 ± 2.7* 8.3 ± 2.6§ 
Peak left ventricular pressure (mm Hg) 158 ± 12 136 ± 29t 156 ± 13 118 ± 22t 124 ± 15§ 
Mean aortic pressure at onset of 98 ± 4 95 ± 5* 88 ± 4§ 
ventriculogram (mm Hg) 
Mean aortic pressure (mm Hg) 98 ± 4 94 ± 2* 99 ± 3 83 ± 3t 89 ± 5§ 
EDV (ml/m2) 87 ± 5 93 ± 6 80 ± 3§ 
ESV (mllm2) 30 ± 3 52 ± 6t 37 ± 4§ 
SV (ml/m2) 57 ± 3 41 ± 5 43 ± 7 
Positive dP/dT (mm Hg/s - I) 1,390 ± 150 1,043 ± 165t 1,375 ± 145 1,335 ± 205 1,180 ± 185:j: 
Negative dP/dT (mm Hg/s - I) 1,515 ± 170 1,100 ± 145t 1,505 ± 175 1,460 ± 220 1,170 ± 150 
T (ms) 44.2 ± 6.2 62.3 ± 11.3t 45.1 ± 3.8 47.9 ± 4.7 54.4 ± 9.2§ 
TI (ms) 50.4 ± 7.2 79.8 ± 16.3t 48.8 ± 8.5 49.9 ± 4.6 65.2 ± 1O.4§ 
T2 (ms) 38.9 ± 6.8 49.3 ± 9.lt 40.2 ± 7.3 40.0 ± 6.4 47.3 ± 9.7 
*p :5 0.05 versus preceding control; tp :5 0.01; :j:p :5 0.05 versus PTCA; §p :5 0.01 versus PTCA. Maximal hemodynamic changes after nitroglycerin 
administration occurred in the first 30 seconds, while balloon inflation began 30 seconds after nitroglycerin, explaining the differences between variables 
in these groups. Because of these rapid changes immediately preceding balloon inflation after nitroglycerin administration (TNG-PTCA), a control period 
for TNG-PTCA was not defined, and this group was compared only with standard balloon inflation (PTCA). EDV = end-diastolic volume; ESV = end-
systolic volume; L VEDP = left ventricular end-diastolic pressure; T = time constant of isovolumic relaxation; TNG = nitroglycerin; T 1 = time constant 
of first 40 ms of isovolumic relaxation; T2 = time constant of second 40 ms of isovolumic relaxation; - = not measured. 
of chest discomfort similar to their anginal pain (Table 4) 
and 7 developed I mm or greater ST segment changes. After 
nitroglycerin, mean time to development of both chest pain 
and electrocardiographic changes was significantly delayed 
(Table 4). 
Duration of balloon inflation. Average balloon infla-
tion times were slightly but insignificantly shorter in stand-
ard balloon inflation as compared with inflations preceded 
by nitroglycerin (54 ± 5 and 69 ± 8 seconds, respectively). 
Two patients developed substantial angina-like pain and 
electrocardiographic and hemodynamic changes consistent 
with ischemia within 20 seconds of standard balloon infla-
tion, leading to early balloon deflation. After nitroglycerin 
administration, balloon inflation was tolerated without sim-
ilar signs of ischemia until at least 55 seconds in both patients. 
Discussion 
Excessive myocardial ischemia during the balloon infla-
tion period of coronary angioplasty is undesirable. In this 
study, occlusion of the proximal left anterior descending 
coronary artery by balloon inflation resulted in a marked 
increase of left ventricular filling pressures, depression of 
global t'jection fraction, deterioration of segmental wall mo-
tion anu the development of angina-like pain and ischemic 
changes on the electrocardiogram. Such changes are similar 
to those reported by other investigators (12,15) in proximal 
left anterior descending artery occlusion during balloon 
inflation. 
When nitroglycerin was administered immediately before 
balloon inflation, several of these sequelae were blunted. 
Table 2. Comparison of Coronary Artery Flow Variables in IO Patients During the 
Balloon Inflation Phase of Standard Balloon Inflation and Balloon Inflation Preceded by 
Nitroglycerin Administration 
Mean aortic pressure (mm Hg) 
Distal coronary artery pressure 
(wedge) (mm Hg) 
L VEDP (mm Hg) 
Perfusion index 
(distal coronary artery pressure 
[wedge] - LVEDP) (mm Hg) 
Control 
98 ± 4 
54 ± 9 
9.2 ± 2.1 
45 ± 4 
PTCA 
94 ± 2 
33 ± 4 
19.4 ± 2.9 
14 ± 5 
p Value 
TNG-PTCA (PTCA versus TNG-PTCA) 
89 ± 5 < 0.01 
32 ± 3 NS 
8.3 ± 2.6 < 0.025 
24 ± 4 < 0.05 
Distal coronary artery pressure is defined as coronary wedge pressure during balloon inflation. Abbreviations 
as in Table I. 
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Table 3. 
Segment 
2 
3 
4 
5 
6 
7 
8 
9 
EF(%) 
Ventricular Segment Comparison 
p Value 
Normal (PTCA 
(%) Control versus Control) 
(41 to 65) 58 :!:: 5 
(41 to 69) 39 :!:: 6 0.02 
(38 to 66) 39 :!:: 5 0.001 
(43 to 71) 44 :!:: 5 0.001 
(23 to 61) 21 ± 4 0.025 
(44 to 66) 54 ± 4 0.001 
(33 to 49) 45 :!:: 5 0.05 
W~ t041) 37 ± 3 
(8 to 34) 15 ± 3 
55 to 81 66 ± 2 0.01 
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... p Value p Value 
(PTCA versus (Control versus 
PTCA TNG-PTCA) TNG-PTCA TNG-PTCA) 
49 :!:: 4 46 :!:: 5 
19 :!:: 3 15 :!:: 3 < 0.01 
8 :!:: 4 \0 :!:: 4 < 0.001 
7 ± 3 5 ± 7 < 0.001 
4 ± 7 2 ± 4 < 0.001 
18 ± 5 0.05 30 ± 5 < 0.05 
30 ± 4 0.05 43 ± 4 
33 ± 3 0.05 42 ± 3 
16 ± 4 20 ± 4 
44 ± 2 49 ± 3 
Segmental left ventricular wall motion. Values are expressed as percent chordal shortening. EF = global 
ejection fraction: other abbreviations as in Table I. 
The increase in left ventricular end-diastolic pressure, pro-
longation of the time constant of isovolumic relaxation (T) 
and shift of the left ventricular pressure-volume curve were 
lessened and the development of chest pain and ST segment 
changes was delayed. Global ejection fraction was slightly 
less depressed, and inferoapical segmental wall motion was 
significantly improved, 
Mechanisms of ischemia amelioration. There are sev-
eral possible mechanisms by which these salutary effects of 
nitroglycerin may be explained. Decrements in myocardial 
wall tension, due to lessening of left ventricular afterload 
and preload, decrease myocardial oxygen demand. Because 
as much as 50% of the ischemic zone after acute coronary 
occlusion is only mildly to moderately ischemic (16), such 
changes alone could significantly improve the balance be-
tween oxygen supply and demand in these areas. Increased 
oxygen supply as a result of increased collateral flow is also 
possible and is suggested by the finding of unaltered coro-
nary wedge pressure despite the decrease in mean arterial 
pressure after nitroglycerin. Such an increase in collateral 
flow could be explained by decreases in coronary resistance 
in large collateral vessels, which would be susceptible to 
the substantial effects of nitroglycerin on large coronary 
Figure 1. Left ventricular wall segments as analyzed by the com-
puter-based system. 
conductance vessels (17,18). Such collateral vessels can 
develop to a functionally important extent very rapidly after 
total vessel occlusion (19,20) and their existence and quick 
recruitment would be predicted by the coronary wedge pres-
sures found in the patients in this study (21). In dogs, whose 
extent of preformed collateral vessels is probably more sim-
ilar to that of human beings with preexisting high grade 
stenoses, such as the patients in this study, nitroglycerin 
results in a marked increase in collateral flow after coronary 
occlusion (22,23) and increases in collateral flow and seg-
mental function in moderately ischemic areas (24). An in-
crease in collateral flow distal to an acute coronary occlusion 
despite a decrease in arterial pressure has also been measured 
in human subjects after nitroglycerin administration (25). 
Because venous pressures usually decrease after nitro-
glycerin, as did the filling pressures in our study, increased 
Figure 2. Left ventricular volumes plotted against concomitant 
pressures for the diastolic portion of cardiac cycles in a represen-
tative patient. PICA = standard balloon inflation during percu-
taneous transluminal coronary angioplasty. TNG-PICA = balloon 
inflation after administration of nitroglycerin. 
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Table 4. Time to Development of Angina-like Chest Pain or I 
mm ST Segment Change 
Time to pain (seconds) 
Time to electrocardiographic 
changes (seconds) 
Abbreviations as in Table I. 
PTCA 
29 ± 3 
30 ± 3 
TNG-PTCA 
58 ± 6 
62 ± 8 
p Value 
< 0.01 
< 0.01 
total perfusion pressure and flow are a likely result of a 
stable coronary artery wedge pressure, as reflected in our 
perfusion index. When maximal autoregulatory dilation has 
been achieved, as might be expected in these patients with 
total vessel occlusion superimposed on a tight stenosis, myo-
cardial flow distal to a coronary stenosis has been shown to 
be directly related to perfusion pressure (22,26). In addition, 
resistance of the anterior cardiac vascular bed further de-
creases when nitroglycerin is administered to patients after 
left anterior descending artery occlusion (18), perhaps in 
part because decreased subendocardial tissue pressure also 
independently decreases effective coronary resistance (26). 
Thus, myocardial flow may increase even more after nitro-
glycerin in relation to a given perfusion pressure. Insofar 
as increased collateral flow is operative in the salutary effects 
seen in these patients, results during occlusion of coronary 
vessels other than the left anterior descending artery may 
be even more auspicious, because evidence exists suggest-
ing that among coronary vessels the left anterior descending 
artery is most poorly collateralized (27). 
Direct versus indirect effects of nitroglycerin. 
Alternatively, nitr~glycerin may have improved left ven-
tricular hemodynamics through its direct pharmacologic ef-
fects, not indirectly through amelioration of ischemia. Ni-
troglycerin can decrease left ventricular filling pressure in 
normal subjects, for example (28), and decreased afterload 
after nitroglycerin administration could have resulted in de-
creased end-systolic volume and improved inferior wall mo-
tion. Although improvements in wall motion after nitro-
glycerin administration are usually limited to mild to mod-
erately ischemic segments (24), and isolated afterload changes 
of the magnitude seen in this study are reported to be without 
significant effect on ischemic or nonischemic myocardial 
segment motion (29), nonischemic segment motion can oc-
casionally improve after nitroglycerin (30). Although our 
model of well defined single vessel stenosis and occlusion 
avoids the confounding influences on segmental wall motion 
of stenoses in adjacent vascular beds (31), the techniques 
used in this study do not allow resolution of these issues. 
Isovolumic relaxation. Nevertheless, several of the ob-
served improvements after nitroglycerin administration can-
not be ascribed to the direct effects of nitroglycerin. The 
time constant of isovolumic relaxation, for example, is sen-
sitive to ischemia both in animal models (32) and in human 
subjects (33) and has been reported to be minimally depen-
lACC Vol. 6. No.2 
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dent on heart rate and loading conditions (32,34). Although 
this insensitivity to loading conditions is not absolute (35), 
administration of intravenous nitroglycerin to human sub-
jects, even when creating greater hemodynamic changes 
than those developed in this study, have been without effect 
on the time constant of isovolumic relaxation (9,36), and 
this constant was not significantly altered in the patients in 
this study during the period of maximal effect of nitroglyc-
erin before balloon inflation. 
The prolongation of the time constant of isovolumic re-
laxation that develops during balloon occlusion of the left 
anterior descending artery is largely secondary to dyssyn-
chronous wall motion (12, IS) similar to abnormal motion 
reported after coronary occlusion of any type (14,37). This 
prolongation can be normalized only when the wall motion 
abnormality is corrected (36), and when regional analysis 
is carried out normalization using antiischemic medications 
can be shown to have effects only in ischemic areas, not in 
surrounding normal tissue or scar tissue (37). Thus, the 
blunting of occlusion-induced changes in time constant after 
nitroglycerin administration likely represents improved wall 
motion in ischemic areas, as suggested by the improvement 
in dyssynchronous motion, probably secondary to dimin-
ished ischemia (34). It has also been suggested that analysis 
of regional myocardial relaxation, rather than global relax-
ation variables, would reveal even more impressive evi-
dence of ischemia amelioration (37). 
Pressure-volume relation. The movement of the dis-
placed left ventricular pressure-volume curve "downward" 
and to the left also suggests that amelioration of ischemia 
plays a role additive to the physiologic effects of nitro-
glycerin. Decrements in left ventricular volumes due simply 
to the unloading effects of nitroglycerin would be expected 
to move the pressure-volume relation along the same curve, 
rather than shifting to a new pressure-volume relation. How-
ever, shifts of the left ventricular pressure-volume relation 
after nitrate administration have occasionally been reported 
(28) in patients with coronary artery disease but without 
known cardiac ischemia. 
Anginal pain and ST depression. Finally, the deJel-
opment of anginal pain and I mm ST depression in this 
patient group is probably a very specific, albeit insensitive 
(38) marker of left ventricular ischemia. Both were delayed 
in onset after nitroglycerin administration. These changes 
are more integrative and not directly dependent on specific 
hemodynamic effects that could be directly altered by ni-
troglycerin and, thus, they more specifically reflect left ven-
tricular ischemia. In a study limited to amelioration of these 
two variables during balloon inflation, Schreiner et al. (6) 
also reported that intracoronary nitroglycerin could signif-
icantly prolong time of onset for these variables when bal-
loon inflation tolerance was specifically investigated. 
Clinical implications. Regardless of the mechanisms of 
nitroglycerin-induced improvement in hemodynamics and 
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segmental wall motion, it could nevertheless be clinically 
useful, especially in patients already compromised with im-
paired left ventricular function or unstable angina, who would 
need only transient support during coronary angioplasty. 
Unlike nifedipine, nitroglycerin can afford protection from 
ischemia without intrinsically impairing left ventricular 
function (3). In no patient in this study did any of the 
variables used to assess left ventricular function and isch-
emia clearly worsen after nitroglycerin administration. 
Conclusion. Nitroglycerin administered before the bal-
loon inflation of coronary angioplasty can significantly blunt 
the subsequent development of symptoms and abnormalities 
in segmental wall motion and hemodynamic variables, at 
least in part through reduction in ischemia. This could be 
important in patients in whom balloon inflation during an-
gioplasty leads to clinically significant degrees of left ven-
tricular ischemia, which is becoming increasingly frequent 
as the cumulative time of balloon inflation per procedure 
increases. Such a simple prophylactic intervention may im-
prove the safety margin for this procedure. 
We thank Michael Fifer, MD for his careful review of the manuscript. 
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